Global Biosensors Market is Expected to be Worth US$ 43,073.2 Million
Biosensors are integrated devices that can analyze biological materials and provide analytical information. They're utilized to figure out how molecules like DNA and proteins work, as well as for medical diagnostics. Disease monitoring, drug discovery, disease-causing microorganisms, and markers that are signs of disease in body fluids such as blood, urine, saliva, and perspiration are all common uses for biosensors.
Drivers of the Global Biosensors Market
Over the forecast period, the worldwide Biosensors Market is expected to rise due to the rising prevalence of chronic diseases. According to a study published in September 2019 in the journal Diabetes Research and Clinical Practice titled "Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition," 463 million people are expected to have diabetes in 2019, rising to 578 million by 2030 and 700 million by 2045. Furthermore, the growing geriatric population is likely to increase the demand for biosensors. According to the United States Census Bureau, the elderly population in the United States is predicted to reach 77 million by 2034.
Opportunities in the Global Biosensors Market
For companies in the worldwide Biosensors Market, R&D to improve the mechanical and electrical properties of biosensors is likely to offer lucrative growth prospects. Carbon nanostructures are biocompatible, have the capacity to immobilize receptors, and have great electrical capabilities as a transducer. This enables them to be used in the development of biosensors that are both efficient and biocompatible. Furthermore, the use of organic semiconductors and conducting polymers in electrochemical biosensors is likely to contribute to the market's growth. Organic semiconductors and conducting polymers offer a greener and less expensive alternative to transition metal or oxide electrodes.
Market Trends
The market's major players are concentrating on increasing their manufacturing capacity. For example, Nemaura Medical, Inc. upgraded its manufacturing facilities in March 2018 to accommodate the large-scale production of their new SugarBEAT CGM system. Over the forecast period, the Global Biosensors Market is Expected To Develop due to an increase in the prevalence of cardiovascular disease (CVD). According to the American Heart Association's Heart and Stroke Statistics 2019 Update, nearly half of all individuals in the United States had a cardiovascular disease in 2016.
Comments
Post a Comment